Ingredion Incorporated

Good day and welcome to the Ingredion Q3 2025 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Mr. Noah Weiss, Vice President of Investor Relations. Please go ahead.

Good morning, and welcome to Ingredion's third quarter 2025 earnings call. I'm Noah Weiss, Vice President of Investor Relations. Joining me on today's call are Jim Zally, our President and CEO, and Jim Gray, our Executive Vice President and CFO. The press release we issued today, as well as the presentation we will reference for the third quarter results, can be found on our website, ingredient.com, in the investor section. As a reminder, our comments within the presentation may contain forward-looking statements. These statements are subject to various risks and uncertainties and include expectations and assumptions regarding the company's future operations and financial performance. Actual results could differ materially from those estimated in the forward-looking statements, and Ingredient assumes no obligation to update them in the future as or if circumstances change. Additional information concerning factors that could cause actual results to differ materially from those discussed during today's conference call or in this morning's press release can be found in the company's most recently filed annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. During this call, we also refer to certain non-GAAP financial measures, including adjusted earnings per share, adjusted operating income, and adjusted effective tax rate, which are reconciled to U.S. GAAP measures in Note 2, non-GAAP information included in our press release and in today's presentation appendix. With that, I will turn the call over to Jim Zali.

Thank you, Noah, and good morning, everyone. The third quarter was more challenging than we expected, with net sales and adjusted operating income down more than our previous guidance. Despite Q3's results, we are, however, confident that Ingredion's diversified business portfolio will deliver another full year of operating income growth. As we discuss the performance in the quarter, we will highlight the progress we are making to improve upon recent and near-term operating challenges while navigating with agility pockets of economic weakness and uncertainty by remaining focused on driving innovation, and operating excellence to deliver profit growth. Turning to the next slide, let's start with a summary of our net sales volume growth for the quarter. Texture and Healthful Solutions delivered a solid performance with 4% sales volume growth across U.S., Canada, and EMEA, including double-digit sales increases for clean label ingredient solutions. Growth in food service channels globally, as well as for convenient grab-and-go offerings at retail, drove increased demand for our batter and breading ingredients in the quarter. Additionally, our solutions portfolio continues to grow, outpacing the segment's net sales growth thanks to increased demand for specialty blends that help customers address affordability, eliminate artificial ingredients, and simplify labels. In food and industrial ingredients LATAM, the main driver of the sales volume decrease came from softer brewing industry volumes, with customers attributing it to cooler, wetter weather for some of the seasonal decline. More broadly, weaker LATAM demand became increasingly evident as higher inflation and interest rates impacted consumer spending. Our food and industrial ingredients US-Canada segment experienced a 5% decline in net sales volume, largely due to our inability to meet customer demand requirements from continued production challenges at our Chicago plant, as well as overall softness in beverage and food volumes. In contrast, we saw increasing volume demand for industrial starches to our major corrugating and paper and packaging customers. Moving to the next slide, I would like to take a moment to elaborate on the primary factor contributing to our food and industrial ingredients U.S.-Canada performance, and that is the ongoing operational challenges at our Argo facility outside of Chicago. For background, Argo is one of the largest plants in our network and accounts for more than 40 percent of the segment's net sales. Following a fire in our feed dryer at the end of quarter two, which halted the entire plant's production, we faced several challenges while plant operations recovered during the third quarter. This quickly and directly contributed to tighter inventories being available for incremental sales. Given the size of the volumes that move through this plant on a daily basis, we estimate that the cumulative operating income impact to the segment was approximately $22 million across both the second and third quarters with $12 million of that operating income impact being felt in quarter three. Production rates remain challenged in July and August before improving in September. In quarter four, our team remains focused on stabilizing production and rebuilding inventories. Also in the quarter, we experienced the overall market demand for sweetener products weakening in July and August before bouncing back in September. We believe many beverage and food customers were experiencing slowing demand as a result of price increases that were put into effect to offset anticipated rising packaging costs, particularly from aluminum and tin plate. Turning to the next slide, our food and industrial ingredients LATAM segment saw a decrease in operating income this quarter, down 11% versus last year. The reduction is primarily attributable to the strategic realignment of our brewing customer mix, as well as lower brewing industry volumes. We are making good progress strategically diversifying our customer and product mix in LATAM towards higher margin sweeteners that serve food and confectionery customers. We will continue to repurpose our grind to improve the consistency of profit margins over time. Beyond what we believe was a transitory impact from the brewing segment in the quarter, we are monitoring softer consumer demand in general across LATAM, which became increasingly evident in quarter three as higher inflation and rising interest rates weigh upon GDP growth and consumer spending. Turning to the next slide, it is important to reinforce the fact that we have made considerable progress to expand the company's gross margins over the last three years through a combination of service differentiation, operational excellence, and solutions selling. We are focused on not only sustaining the performance, but steadily improving upon it by executing against our strategic pillars to drive mix improvement and enterprise productivity. Let me now update you on progress against our three strategic pillars. To start, I'd like to highlight our focus on driving profitable growth, particularly within texture and healthful solutions segment, where we continue to expand our leadership in clean label ingredients and solutions globally. North America and Asia-Pac experienced double-digit clean label growth this quarter, reflecting a growing demand from customers and consumers for greater transparency and simplicity in ingredient labeling. This trend has become mainstream, with both private label and CPG consumers reformulating products at an accelerated pace. Additionally, demand for protein isolates remains robust, as evidenced by our record sales for protein fortification during the quarter and the fact that we are already more than 50% contracted for isolates for 2026. Our high-value pea protein isolates offer notable functional advantages and benefits from labeling preferences compared to other protein sources across various food categories, with our new product introductions being preferred for their taste, and overall quality. Moving now to our second pillar, innovation. Our focus on integrated solutions continues to favorably impact Texture and Healthful's results, with solutions-based sales growing at a faster rate than the overall segment's net sales growth for the quarter. Furthermore, as food inflation pressures persist, affordability remains a key catalyst for recipe reformulation across our customer base. Brands are actively seeking our assistance with cost-effective ingredient solutions that allow them to maintain quality and shelf life while reducing input costs. Our latest innovations in egg and cocoa replacement solutions deliver cost savings, improved functionality, and enhanced flavor profiles. By enabling customers to reformulate recipes without compromising taste or texture, we're helping them differentiate their products and respond quickly to market trends. As consumer demand for natural sweetness continues to increase, Ingredion is advancing development partnerships for sweet proteins and novel customized clean taste solutions containing stevia and sweet proteins. We believe this will further strengthen Ingredion's position as a leader in sugar reduction innovation. Lastly, I'd like to comment on our operational excellence pillar. Our operational focus has translated into meaningful benefits at our Indianapolis facility, where we've taken steps to maximize asset utilization across our starch network. By modernizing the plant layout and reengineering slurry transfer systems, we've created flexibility to run specialty starch operations in a more integrated manner with downstream operations. This means fewer bottlenecks, better load balancing, and improved throughput. These changes reduce inventory requirements, enhance service levels, and deliver meaningful savings, all while better positioning the plant to support future growth for texture solutions. Additionally, we feel confident we will surpass our $50 million run rate cost to compete savings target and will realize more than $55 million in run rate savings by the end of 2025. This achievement reflects a relentless focus on operational efficiency and disciplined cost management across the organization. By optimizing processes, eliminating waste, leveraging technology, and driving continuous improvement initiatives, we've been able to unlock significant savings. Last month, we hosted our first ever Supplier Day, bringing together strategic partners from across our supply chain globally in the pursuit of shared value creation. This was a valuable forum for collaboration, knowledge sharing, and strengthening of relationships. The event created increased awareness and understanding by our suppliers of our business and is already leading to new opportunities for value creation for us and them. Lastly, in October, we held a global AI forum for our entire employee base to accelerate adoption for the responsible usage of AI. Our AI priorities for value creation are focused on enhancing the customer experience, driving supply chain and manufacturing efficiency, and accelerating innovation. Now, I'm pleased to hand it off to Jim Gray for the financial review. Jim? Thank you, Jim, and good morning, everyone.

Moving to our income statement. Net sales for the third quarter were $1.8 billion, down 3% versus prior year. Gross profit dollars decreased by 5%, with gross margins slightly lower at 25.1%, as volume headwinds were partially offset by lower input costs. Reported and adjusted operating income were $249 and $254 million, respectively. Turning to our Q3 net sales bridge, The 3 percent decrease was driven by $39 million in lower volume and $30 million in lower price mix, offset partially by $15 million of favorable foreign exchange. Moving to the next slide, we highlight net sales drivers for the third quarter. Texture and healthful solutions net sales were up 1 percent, driven by sales volume growth of 4 percent and foreign exchange favorability of 2 percent. partially offset by price mix. Food and industrial ingredients LATAM reported a net sales decrease of minus 6%, largely attributed to a reduction in sales volumes, which was mainly influenced by weaker brewing demand, as well as slower macroeconomic growth across the segment. Food and industrial ingredients U.S. canned net sales declined 7%, The sales volume decline of 5% was impacted by the extended recovery time to normalize production at our Argo plant, as well as softness and sweetener volume demand. Now let's turn to a summary of results by segment. For the third quarter 2025, texture and healthful solutions net sales was up 1% and operating income was up 9%. equating to a 17.4% operating income margin, significantly higher than prior year. This result has been driven by lower raw material costs, as well as favorable volume impact, partially offset by unfavorable price mix. In food and industrial ingredients LATAM, net sales were down 6% versus last year. Operating income declined to $116 million. with an operating income margin at 19.8% holding strong. Moving to food and industrial ingredients, U.S. can, third quarter net sales were down 7%. Operating income was $81 million, down 18% or $18 million, driven by production challenges at our Argos plant and lower than expected beverage and food volume demand. As we stated earlier, we estimate that this disruption has had a $12 million operating loss impact on the quarter's results. For the all other group of businesses, the 17% increase in net sales was driven by increases across the board. Operating income was flat versus the prior year as protein fortification gains were offset by lower profits from the Pakistan business. Turning to our earnings bridge, on the top half you can see the reconciliation from reported to adjusted earnings per share. Operationally, we saw a decrease of 31 cents per share for the quarter, driven by a decrease in operating margin of 22 cents and a volume of minus 12 cents, partially offset by foreign exchange of 3 cents per share. Moving to the change in non-operational items, we had an increase of $0.01 per share. Shares outstanding had a favorable impact of $0.05 and a lower tax rate equivalent had a $0.02 per share impact, partially offset by higher financing costs of minus $0.06 per share. Shifting to our year-to-date income statement highlights, net sales for the first nine months were approximately $5.5 billion, down 3% versus prior year. Gross profit dollars grew by 4%, and gross margin has increased to 25.6%, up 180 basis points. Reported and adjusted operating income were 796 and $800 million, an increase of 10% and 4%, respectively. Turning to our year-to-date earnings bridge, the result is an increase of 58 cents per share. Operationally, we saw an increase of 36%. cents per share for the nine months the increase was driven by an operating margin increase of 61 cents as well as favorable other income of 14 cents per share primarily from our argentina joint venture and these were partially offset by volume of minus 38 cents moving to the change in non-operational items we had an increase of 22 cents per share primarily driven by fewer shares outstanding of 15 cents, as well as lower financing costs and tax rate of 3 cents per share each. Moving to cash flow. Year-to-date cash from operations was $539 million, which includes an investment in working capital in the current year. Year-to-date capital expenditures net of disposals were $298 million. the company expects to invest in organic growth initiatives that provide a significantly higher return than our cost of capital. Lastly, we have repurchased 134 million of outstanding common shares, exceeding our share repurchase target of 100 million. We have paid out 157 million in dividends and increased the dividend per share to 82 cents for the quarter, which represents our 11th consecutive annual dividend increase. Now let me turn to our updated outlook for the year. For the full year of 2025, we anticipate net sales to be flat to down low single digits, with our outlook reflecting lower price mix due to the pass-through of corn costs and an updated view of the effects of foreign exchange. We anticipate that adjusted operating income will be up low single digits to mid single digits for the full year. Our 2025 financing cost estimate will now be in the range of $35 million to $40 million, reflecting year-to-date foreign exchange impact. For the full year of 2025, we expect a reported effective tax rate of 25.5% to 26.5% and adjusted effective tax rate of 26% to 27%. We are narrowing our full-year adjusted EPS range to be $11.10 to $11.30, given the macroeconomic softness evident in the third quarter for Latin America economies and the incremental issues that we absorb related to F&I U.S. can segments Chicago plant outage. We anticipate our 2025 cash from operations will now be in the range of $800 million to $900 million. Our guidance reflects current tariff levels in effect at the end of 2025. In addition, this guidance excludes any acquisition-related integration or restructuring costs, as well as any potential impairment costs. Turning to the full-year outlook for each segment, where we have made updates. For texture and healthful solutions, our estimate for net sales is to be up low single digits. we have raised our operating income profit growth to now be up high double digits. For F&I LATAM, we have lowered our net sales outlook to be down mid single digits and operating profit to be flat to up low single digits. For F&I US Canada, we have now lowered our outlook for net sales to be down mid single digits and operating income to be down low double digits based upon operating challenges. That concludes my comments, and I'll turn it back over to Jim.

Thank you, Jim. As we conclude today's call, I want to emphasize the focus we have on our operational and strategic priorities. Clearly, we have a near-term focus on improving productivity at Argo and rebuilding inventories and driving sales recovery in our U.S. food and industrial ingredients segment. Complementing this focus on operational excellence, the entire organization is committed to exceeding its cost to compete target, delivering $55 million of run rate savings by year end. We will continue to deploy capital towards organic growth opportunities to expand and strengthen our texture and healthful solutions portfolio. Lastly, we remain committed to returning capital to shareholders through share repurchases. As of the end of September, we exceeded our full-year target by purchasing $134 million worth of shares and have increased our 2025 share repurchase target to $200 million. Underscoring our commitment to maximizing shareholder value and reflecting our confidence in the future, we are announcing that our Board has authorized a new share repurchase program of up to 8 million shares over the next three years. Now, let's open the call for questions.

Thank you. As a reminder, to ask a question, please press star 1-1 on your telephone and wait for your name to be announced. To withdraw your question, press star 1-1 again. Due to time restraints, we ask that you please limit yourself to one question and one follow-up question. Please stand by while we compile the Q&A roster. And our first question will come from the line of Andrew Strelzyk with BMO Capital Markets. Your line is open.

Hey, good morning. Thanks for taking the questions. I wanted to start on the demand environment, and I apologize if you covered some of this in the prepared remarks that I missed. But, you know, I guess I'm just curious how you're seeing that evolve. It certainly seems a bit softer than anticipated. And so I guess, are you seeing it continue sequentially to to slow? Are you seeing any signs of stabilization? And in the release, you mentioned some customer mix management. I was hoping you could maybe elaborate on that as well.

Yeah, Andrew, I'm going.

Ladies and gentlemen, please remain on the line. Your conference will resume shortly. Once again ladies and gentlemen please remain on the line. ladies and gentlemen please remain on the line your conference will resume shortly once again ladies and gentlemen please remain on the line Mr. Strelczyk, I just want to make sure that you can hear me.

I can, yes.

Okay, just one moment. Speakers?

Yes, we're here. Yes, we're back, yeah.

Okay, you're loud and clear, and we still have Andrew on the line for his question.

Okay, Andrew, I'm going to start back with the response related to what's happening in LATAM. And with Mexico and Brazil, I think that's where the line got cut off. Is that correct?

Yeah. I mean, the question was broadly about the demand backdrop, you know, and if you're seeing any signs of stabilization. But then there was the comment, I think it was in LATAM, about the mix management, customer mix management. Right, right, right.

Yeah. So in Brazil and in Mexico, we're seeing inflation, elevated prices that are impacting the consumer. Interest rates are relatively high versus history. And we do believe that's impacting consumer spending and confidence. Mexico GDP is forecasted to only grow 0.5%. And Brazil's GDP is forecasted to grow only 2%. It's just noteworthy to remind everyone that food spending represents approximately 20% to 30% of disposable income for the lifetime consumer. And thus, when we see softness and thus Thus, we're seeing the cumulative impacts related to softness in beverage and multiple food categories. Moving to the United States, we saw demand for sweeteners in particular decrease in July and August. That's what the industry data showed. It was a pretty notable drop in July and August, but it did recover nicely. September so but for the quarter July and August was impacted and of course we at the same time in those months had issues related to Argo depletion of inventories inability to sell but things picked up in September and again as it relates to texture and healthful we didn't see that kind of decline in fact the US market contributed most to volume net sales and operating income growth, but all three geographies grew operating income high single digits for global and texture and healthful. Hopefully that answers the question.

It does. Thank you. And as a follow-up, I was hoping you could drill down a little bit more on the texture and healthful solution segment. The change in the outlook there, is that What kind of is the biggest driver of that piece? Is it more what you saw in 3Q? Is it more what your expectation is for the 4Q? I was just looking for a little more color on the guidance change there. Thank you. Jim Gray, I'm going to let you take that.

Andrew, I mean, I think that as we look at Q4, we have from prior years kind of a slightly easier lap. But I think more importantly... When we look across texture and healthful, it's really a diversity of customers. And so, you know, we have some of our largest customers that are in food service. We also have customers that are into private label as well as kind of branded CPG. So, you know, when affordability and value against either the U.S. or the European consumer, we're already benefiting a bit from, you know, what that sort of food service traffic and food service ticket looks like, as well as whether it's store brands or private label brands, I think we're seeing a nice balance of our volume demand across all of our customers. And so we feel like that's a well-diversified, very solid business right now that has some growth right in front of it.

And we're also benefiting from a focus with a well-defined definition for solutions selling. where we've went through a complete retraining of our go-to-market sales and technical service force, and we're into the second full year of, I would say, more advanced solution selling than we've ever had in relationship to selling differentiating ingredients, customized blends and solutions, all around consumer benefit platforms, around affordability, health and wellness, which are really aligned to the trends. And that's why I think we're seeing the strength in our clean label solutions growth, which again grew double digits in the US and Asia pack. Great, thank you very much.

Thank you. One moment for our next question. That will come from the line of Kristen Owen with Oppenheimer. Your line is open.

Hi, good morning. Thank you for taking the question. Jim, Jim, I did want to follow up on the F&I businesses. You gave some helpful color on Argo in the prepared remarks, but can you just help us unpack how much of the volume was sort of this macro weakening that you addressed in the first question? How much of that was sort of these company-specific events like the Chicago plant or this transition in your brewing business in LATAM? And I'm just trying to think how much of those one-time items kind of roll off in the fourth quarter and what sticks with us. If we could start there, and then I'll have a follow-up, please.

Hey, Kristen, can we just clarify which segment? So U.S.

CAN, F&I first? Yeah, why don't we take U.S.-Canada F&I first, Jim, and then maybe I'll take the LATAM F&II. Yeah, okay.

Is that okay, Kristen?

Yeah?

Yes, I was hoping to get both, so thank you.

Okay. Okay. So I think with regard to, you know, US CAN, FI, and I, so first of all, you know, as Jim mentioned on the pre-recording, that the, you know, the feed dryer is very much at the end of the process. When that goes down, the entire plant has to shut down. And so then as we looked at those, we just, we wanted to bring up the full recovery of the plant. And so we had a couple impacts in terms of You have some lower value from your co-products that you got to clear out. You also had some periodic halting of the grind, which impacted a variety of the refinery processes. And so we didn't have as much volume available. We also had to absorb some fixed costs. And then as we got running to kind of normal production rates in September, you can really put a kind of cap on those costs. that cap is around, you know, $12 million impact to Q3. Don't really anticipate that that's going to repeat, right? I mean, you know, we want to work on reliability. We think about our planning as we go forward, and obviously we plan to run at normal to full capacities in 2026. So really don't think we're going to overlap, you know, this maintenance and the idle plant charges within U.S. CAN-FI and I.

Right, so 12 of the 18 declined, we would attribute to the Argo issues. The remainder related to the market weakness that we saw, which was very curious with the drop-off in July and August, but the good news is we saw industry recovery in September. So let me pivot, and I'll talk about LATAM. For the LATAM F&II segment, Approximately 40 percent of the revenue decline year on year was attributable to soft brewing volumes. Now, the largest contributing factor was related to the impact of the terms and timing of purchases associated with the rollover of a significant customer's multiyear agreement. That situation is now satisfactorily resolved. and it should not repeat. So for color, in the quarter, Mexico was down 10% with half of the net sales decline due to brewing-related situations to that unique customer situation. And in Brazil, 90% of the decline was due to brewing demand, again, predominantly related to that customer situation. And because brewing adjunct represents 18% of net sales for F&II Latem and a larger percentage of our volume, what we've been doing is we're actively pursuing alternative paths to utilize our grind more profitably by trading up to support higher margin products in food and confectionery. We believe this represents an exciting incremental opportunity to diversify beyond brewing and valorize our grind more profitably. So hopefully that answers the question related to what we believe is some transitory aspects in F&II. We would say about half of the decline in LATAM was due to the brewing transitory nature, and Jim indicated about two-thirds of the decline in F&II US-Canada was related to the Argo situation. Hopefully that's clear.

No, really appreciate all of that color. That is very helpful in helping us understand what goes away in the fourth quarter. My follow-up question is actually, as we're thinking about fourth quarter contracting season, I understand it's a little early on 2026, but just given some of these one-time items in 25, I'm wondering if you can give us a sense of how you're thinking about price-cost dynamics into 2026? I mean, we've had a lot of volatility on the input cost side, and then you've got some of these one-time items on the cost side. So just some of the big buckets that we should think about from a price-cost perspective into 2026 would be very helpful. Thank you.

Yeah, I would say, just as it relates to contracting, obviously, we're early in the process. I would say that we're currently midway through firm price contracting in the U.S. and in Europe, So still a long way to go. And as it relates to inflationary pressures, which there are on input costs, along with U.S. cost of corn projected to be higher in 26 versus 25, we anticipate this is going to prolong customer commitments and that contracting will not be completed until late in the year. And obviously, we always do, we think, a pretty good job of balancing all of the puts and takes, especially given the pricing centers of excellence that we have stood up over the last few years that have served us very well during the inflationary period. And now as we manage a more benign but yet still sticky inflationary period, we're cautiously optimistic that 2026 contracting will position us for another year of modest profit growth based on everything that's happening in the economies globally, along with the backdrop of uncertainty.

Thank you so much.

One moment for our next question. And that will come from the line of Ben Thurer with Barclays. Your line is open.

Yeah, good morning, Jim and Jim. I wanted to follow up on T&H, just the dynamics in the quarter and the outlook. So the first question really is related. If you could elaborate maybe with a few examples on what's been driving the negative price mix in texture and health food solution, which at minus 5% look pretty high. So that's the first thing I would like to understand, and then I'll have a quick follow-up.

Let me have Jim make that comment. Jim? Hey, so Ben, on the price mix, you know, when you look quarter over quarter, right, so some of the pricing that we had coming into the beginning of 2025 from Europe, we had some higher energy costs that were evident in 24, and so as energy costs had come down, that was part of our pricing mix. That's been kind of true all year, as well as... Some of the corn, I think corn was about equal, but we've also seen some higher expected corn costs and like basis for some of our specialty grains. So that's literally, you know, in the prior year that was there. And then as there's been more plentiful corn, some of that basis has come down year over year. So it's really more of a pass through, I think, of some of the either net corn costs or the inputs.

Okay, perfect. And then my follow-up question is really coming back to some of the dynamics in food industrial Latin America and the outlook in particular. So as you're probably aware of, in Mexico there is a proposal out which is about to be approved for a significant increase on taxation for soft drinks, which would not only affect the ones with caloric content, but also the ones with no sugar in it, so no caloric content. at all and still being taxed. And the bottlers down there, the expectation that there's going to be a significant need to pass pricing because of these taxes and with an expectation of large volume declines. So I wanted to understand what is your positioning and how can you kind of like protect maybe volume or what are you doing on your contracting side, particularly in Mexico, as it relates to the sweeteners piece, but also the non-caloric sweeteners as alternatives, which both are going to be impacted by the taxation into 2026.

Jim, why don't you take it first and then I'll pick up on it.

You know, so obviously, you know, what, Ben, you're discussing is this kind of sweetness tax that is across both caloric as well as non-caloric or light beverages that will impact in Mexico. I think that legislation is up for a vote, or maybe it's approved, but the effective date I thought was January 1, 2026. Okay. So on the caloric side, you know, clearly the bottlers in Mexico have a choice between kind of liquefied sugar and HFCS. And we think that as you look at the cost competitiveness and the formulation for HFCS, it should lean a little bit more towards, you know, kind of the use of HFCS. And then it just, and what we've also seen historically when we've seen kind of taxes go into place on beverages is that usually there's an initial sort of sticker shock, but then after that, I think consumers generally kind of sort of accept or work that into their overall cost of their grocery basket or their cost of lunch on the go or dinner. And so there's always usually an initial impact for anywhere between a month to three, four, five months. and then it works through. I think the customers that we have also are very much thoughtful around their price pack architecture, and we'll think about value in those trade-offs. I think for non-caloric sweeteners, it's more of an interesting issue, which is there's a consumption tax going in. Will you see any separation between for beverages that we sell, like maybe a Stevia solution into where you have maybe a unique proposition on that beverage, and that might be able to withstand that tax increase.

Yeah. What I would also say, Ben, is that this proposed increase, which I think is 17 cents a liter on sugary drinks, and again, non-sugary drinks, but sweetened with artificial sweeteners as well, that will go into effect. It's coming now maybe eight years later than the first 6.8% tax that was put in place. And as Jim said, when that went into effect, there was a dampening for six months to nine months on purchases. And then what was interesting is consumer behavior was modified and the tax actually had unintended consequences and impacted purchases of other products outside even the food category where people then went back to products that they liked, which were some of the caloric beverages, especially consumed by laborers and the construction workers, et cetera. And we actually observed that. Now, We'll see what's going to happen this time. But the other important point, Jim, that I think is important for us to highlight is we do not export a lot of, say, HFCS into Mexico. In fact, it's a very small quantity because we produce locally and we're not a large HFCS producer locally. We're much more of a glucose producer locally. So from a standpoint of how directly, so I use the word directly going to be impacted, I don't foresee it will have a direct impact. How it impacts the industry and what indirect effects are kind of remains to be seen, but I do think it won't be a one-for-one that is prolonged. Consumers will adjust, as they did when that tax went into effect in 2016-17, and we'll see then what happens from there. Okay, perfect.

Thank you very much for that clarification. Yep, thank you.

One moment for our next question. And that will come from the line of Puran Sharma with Stevens. Your line is open.

Good morning, and thanks for the question. I just wanted to ask about U.S., Canada, FII. I think you mentioned it in the prepared comments and in the Q&A here. I think you called out 12 million weakness from Argo and 6 million from softer market. And just parsing into that further, you mentioned softness in July and August, but a recovery in September. Were you... speaking on a volume basis, and are you able to kind of share if that recovery has held into October or what you're seeing thus far, quarter to date?

Yeah, I think you've summarized it accurately as it relates to U.S.-Canada, and the comments that we made about July and August in U.S.-Canada are related to volume shipments in the industry of sweeteners, which is what we were specifically talking about. And that recovery in September was also volume related and related to sweeteners. I would say it's early yet in the quarter for quarter four, but we're not, I don't believe, going to see the July and August step downs that we saw from an order of magnitude And we do really believe that it was related to a subset of brand companies, brand food companies, in both beverages and packaged foods, taking price, promoting less, and absorbing higher aluminum and tin plate packaging costs, passing those on, because the 232 tariffs that went into effect actually were announced, I believe, in March. And by the time they started to be manifested at the retail level, we believe that that one-time impact was experienced in those months. And the manufacturers were optimizing their approach to how they were going to price. And thus, the impact was felt by consumers. The adjustments have occurred. And Again, September was evidenced of that. That's how we have interpreted it. And again, we need more data points going forward to really, you know, be conclusive. But that's our best understanding of what took place and how we would explain the impact in the quarter.

Great, great. I appreciate that detail there. And just maybe wanted to understand just Argo a little bit better. Maybe I was wrong in my thinking, but I think last time we had spoke or last earnings call, you were expecting to get some of the volumes back as we work through 3Q and 4Q. So I was just wondering what you are all facing from like a production challenge standpoint. And, you know, do you see these manufacturing issues abating by 2026 or what kind of timeline should we be thinking of here?

Yeah, no, you are correct in what we had expected and what we thought was possible. The point we wanted to make and the point we'll make again is that Argo is a big complex facility, factory, and when it runs well, we can make up for a lot of lost ground. And what we were expecting was that it was going to recover more quickly than it did. And unfortunately, the recovery lasted into the quarter. So not to be repetitive, but when a factory like that of that size goes down, the first challenge that we have, because it impacted what we call the back end, which is the co-products and the feed, is we then lose the valorization premium on coproducts and we have to get the plan up and running and we have to dispose of the coproducts so it doesn't become a bottleneck and it takes time to normalize the quality of those coproducts to get the valorization. In addition, you then have periodic halting of the grind that impacts the downstream refinery processes. And then that leads to product downgrades. And then that leads to underabsorption of fixed costs and unplanned maintenance costs. And we incurred all of that. Again, the production impacts that we experienced, separate from what we saw in the industry from a standpoint of volume, for us was particularly acute in July and August. But September returned to normal production rates. So the team right now is very focused on We don't want to declare victory. We're seeing steady recovery, stabilization, and we're hopeful that, you know, certainly quarter four is going to be better than quarter three. And then as we, you know, go into the winter, assuming we don't hit, you know, we've lived through polar vortexes and those kind of things, assuming we don't have anything like that, we should be on a steady road to recovery at Argo.

Thank you for the call.

One moment for our next question. And that will come from the line of Josh Spector from UBS. Your line is open.

Hi, good morning. So just to follow up on the U.S.-Canada side, just specific for your fourth quarter, I mean, it looks like on your guidance for the year, you know, down low double digits, it maybe implies that your fourth quarter is around $70 million in EBITs. So you're still down around 10 million year over year. I guess, is that right? And is that primarily just comments around weaker market buying and seasonality? Were there any other effects there? And I guess I'll ask my follow-up in addition here that around, does that carry into the first half of next year with some of the comments around weaker consumer buying or not?

Hey, Josh, this is Jim Gray. I think with regard to how we think about the momentum going into Q4, we don't really expect any kind of operational issues or one-time issues, whether if it's the US can Chicago plant operations or kind of the LATAM brewing. But we did want to come back and just say for US can market for the demand for beverages and food, for kind of our sweetener syrups. I think we do see some customers, not just branded, but also private label taking price in the market. They are overcoming package, expected package cost inflation. And our markets are always, our consumer's always gonna be a little elastic. And we've seen this before. It's not dramatic in terms of the overall cost inflation that we're seeing in the market. But you are seeing some unit price increases show up in the scanner data. And I do anticipate that that will carry into Q4. And so that's kind of what's shaped our guidance a little bit. But overall, it's not a shock. I think the US consumer is in a good spot with regard to wages. And affordability is always top of mind. But I think there is some necessary, if not modest, pricing inflation on behalf of some beverage and food customers, and that's going to always slow the demand for sweeteners. But we're in a good spot if that sweetener demand does pick up in Q4, and that's kind of part of our guidance. Okay, thank you.

One moment for our next question. And that will come from the line of Heather Jones with Heather Jones Research. Your line is open.

Good morning. Thanks for the question. And apologies if I repeat anything. I got on the call late. Was wanting to talk about LATAM. And as you're thinking about 26 and, you know, the Mexico tax issue that you discussed, and then just the broader inflation challenges for the consumer, just wondering, I know you're not giving 26 guidance yet, but just wondering, Now, how you're thinking about that setup for next year, particularly given it's, you know, had a couple of really good years. Just was hoping you could give us some cover on that.

Yeah, we let me just make a comment. We just actually celebrated our 100th year operating in Mexico. In fact, we had a board meeting in Mexico and we were able to meet with government officials and we were able to hear from economists and you know, in relationship to the pulse on the economy. And definitely the government's budget deficit in Mexico has presented a challenge along with, you know, the muted GDP growth. So we are seeing a softer Mexican economy. And also some of the companies that we sell to there export to the U.S. and export to a Hispanic community in the U.S. from the standpoint of some of their products and brands. And we all have read from CPG companies in the U.S. about a weaker Hispanic consumer here in the U.S. So clearly, that manifested itself in the shipments that we make to these customers in the U.S. you know, in the third quarter. Not really prior to that. It's starting. And, you know, you're going to have an overhang as well in relationship to USMCA negotiations that will need to be resolved or postponed by July of 26. So there will be, we believe, some uncertainty that will hang over certainly the Mexican economy. And that's kind of what we're anticipating as we exit the year and as we head into the year. That all being said, the position that we hold in the Mexican market is a very solid position, very strong position. And the overall Mexican consumer has been resilient. And affordability is going to be very, very important. That plays to one of our strengths from a standpoint of how we work with customers on recipe development. And we also really know how to optimize our network down there. We've got three great plants, and the team is working very hard to optimize supply chains and look at cost management. So that's kind of the backdrop, and that's how we're approaching it right now. But it's early. It's really early. to project too much forward what we've seen in Q3 into 26 at this point in time.

Okay, thank you for that. And then my next question is just on the share repo. This is a throwback to years ago, but I remember at one point, you know, your shares weren't as liquid as far as how they trade and all, and so that sort of limited the optionality on the magnitude of share repurchases. So I was just wondering if you could update us as far as your thinking on that. Is there a limit to how many you want to repurchase ultimately? And just update a thinking on that.

Yeah. Well, first of all, I mean, why the new authorization from our board on our share repurchase program? So the program that we had in place was set to expire at the end of 25. I think overall we're confident in the growth strategy for the company and believe that organic investment is going to continue to favorably impact cash flow growth. And so if you look at that going forward, then our capital allocation priorities are still around reliability capital, organic growth investment, supporting the dividend. But after that, we have strategic cash to deploy and we have a healthy cash balance today. And so, you know, I think we look at our repurchase history for 2024 and now for 2025 with trying to, you know, exceed $200 million of share repurchases in 2025. So we're going to anticipate that we're going to have kind of more share repurchases in 26, you know, 27, 28, and thus the need to come back and renew our and reauthorize at 8 million shares over that time period.

Okay, perfect. Thank you so much.

Okay.

Thank you. I'm showing no further questions in the queue at this time. I would now like to turn the call back over to Mr. Jim Zally for any closing remarks.

Thank you, Operator, and I want to thank all of you for joining us this morning. We look forward to seeing many of you at our upcoming investor events in the next engagement being the Stevens Annual Investment Conference in mid-November. And at this time, I just want to thank everybody again for your continued interest in Ingredion.

This concludes today's program. Thank you all for participating. You may now disconnect.